INTRODUCTION
Myocarditis has been historically defined as an acute disease process which results in myocardial inflammation and necrosis(1). The often-resultant impairment in myocardial function increases the predisposition to the development of a non-ischemic cardiomyopathy, which has been shown to result in poor prognostic outcomes such as chronic congestive failure, cardiac arrhythmias and sudden cardiac death(1). Whilst the gold-standard investigation is cardiac magnetic resonance (CMR), the initial non-invasive assessment typically utilised is transthoracic echocardiography (TTE), as it is widely available, easily accessible, and cost-effective within most healthcare settings